Pat Dorsey’s Q3 13F: Veeva and Tyler Enter Top 10 as Danaher Exits
Pat Dorsey overhauled Dorsey Asset Management's $1.7B book in Q3 2026, building top stakes in Veeva and Tyler Technologies while dumping Danaher.
Pat Dorsey’s Dorsey Asset Management expanded its concentrated U.S. equity book to $1.7 billion in the third quarter of 2026, orchestrating a major portfolio revamp across just 13 high-conviction holdings. Filed with the U.S. Securities and Exchange Commission on November 16, 2026, the fund's latest disclosures reveal an aggressive shift into mission-critical software moats, headlined by massive new stakes in Veeva Systems and Tyler Technologies alongside a total liquidation of life sciences giant Danaher.
What happened
Form 13F filings reflect only long U.S. equity positions as of September 30, 2026, and are published with a 45-day regulatory delay, omitting international listings, short positions, and cash reserves. Within these parameters, Pat Dorsey executed some of his most decisive capital reallocations in recent years.
The headline transaction was the initiation of Veeva Systems (NYSE: VEEV). Dorsey acquired an estimated $240 million stake, catapulting the life sciences cloud specialist immediately into his top portfolio spot at 14.10%. Tyler Technologies (NYSE: TYL) entered as another heavyweight addition, securing a 7.47% weighting across 401,725 shares. Dorsey also established a new 4.38% position in public safety tech leader Axon Enterprise (NASDAQ: AXON) and parked 1.03% in the iShares MSCI ACWI ETF.
To fund these ambitious software bets, Dorsey Asset Management completely exited longtime core holding Danaher Corp. (NYSE: DHR), which previously accounted for 7.64% of assets, alongside equipment lessor Sunbelt Rentals (NYSE: SUNB), previously 5.51%.
Among existing positions, Dorsey doubled down on advertising technology firm AppLovin (NASDAQ: APP), increasing his share count by 37% to reach a 10.21% portfolio weighting. He also expanded positions in Meta Platforms (+10% shares, 9.30% weight) and S&P Global (+18% shares, 8.58% weight), while adding 12% each to Booking Holdings, Uber Technologies, and Live Nation Entertainment. In contrast, semiconductor equipment bellwether ASML Holding was heavily trimmed: Dorsey slashed the position by 43% in share count, reducing ASML's weighting to 7.85%.
Why it matters
As the former director of equity research at Morningstar, Pat Dorsey authored the definitive modern framework on the economic moat—the durable competitive advantage that enables a company to generate excess returns on invested capital for decades. With only 13 holdings in a $1.7 billion book, every portfolio change reflects decisive, concentrated conviction rather than routine index tracking.
The simultaneous exit from Danaher and entrance into Veeva Systems illustrates a deliberate sector rotation within healthcare. While Danaher has grappled with extended customer destocking and capital expenditure constraints in bioprocessing equipment, Veeva provides essential cloud infrastructure for clinical trials, regulatory submissions, and commercialization across global pharma. Veeva’s proprietary data model and embedded regulatory workflows create exceptionally high switching costs, resulting in near-total customer retention.
Tyler Technologies and Axon Enterprise fit the same structural mold in the public sector. Tyler serves as the digital backbone for local municipalities, court records, and property tax assessments, benefiting from multi-decade replacement cycles and minimal commercial competition. Axon holds an entrenched ecosystem across law enforcement hardware, body cameras, and cloud evidence storage. Both companies operate in non-cyclical niches where software renewals are funded by municipal budgets rather than volatile consumer demand.
Meanwhile, trimming ASML by 43% while expanding AppLovin to 10.21% highlights Dorsey’s response to cyclical headwinds. ASML retains an undisputed monopoly on Extreme Ultraviolet lithography, but the stock faced valuation scrutiny and slowing memory equipment orders. In contrast, AppLovin’s proprietary AXON recommendation engine delivered explosive operating leverage and margin expansion, proving its ability to monetize digital ad real estate outside traditional big-tech walled gardens.
What to watch next
- Veeva's Vault CRM transition: Progress of major pharmaceutical clients migrating to Veeva's standalone platform and its newly introduced life sciences AI tools.
- Tyler's cloud conversion pace: The acceleration of legacy municipal customers flipping to SaaS subscriptions hosted on Amazon Web Services.
- AppLovin's non-gaming expansion: Whether its machine-learning engine can successfully capture meaningful e-commerce and web performance advertising spend.
- Next 13F filing in February 2027: Clarification on whether Dorsey continues unwinding ASML or further concentrates capital into government and public-sector tech.
Stocks in this analysis
AI stock analysis- P/E
- 21.4
- Fwd P/E
- 17.5
- Analyst target (avg)
- $850.59 (+36%)
- P/E
- 34.6
- Fwd P/E
- 22.2
- Analyst target (avg)
- $2,109.51 (+50%)
Free on aktienanalyse.ai: score profile, ratios versus the industry and business model. Plus, if you want it, the full analysis with fair value and bull, base and bear case. Prices and ratios as of Nov 16, 2026.
Sources (3)
This analysis is for information only and is not investment advice. Prices and figures as of publication.